{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:04:21Z","timestamp":1780913061131,"version":"3.54.1"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.31034","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T16:17:48Z","timestamp":1635265068000},"page":"e2131034","source":"Crossref","is-referenced-by-count":29,"title":["Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination"],"prefix":"10.1001","volume":"4","author":[{"given":"Lily","family":"Li","sequence":"first","affiliation":[{"name":"Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lacey B.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Mongan Institute, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Patel","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam B.","family":"Landman","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Emergency Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Fu","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Mongan Institute, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S.","family":"Shenoy","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean M.","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Occupational Health Services, Mass General Brigham, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleena","family":"Banerji","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige G.","family":"Wickner","sequence":"additional","affiliation":[{"name":"Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upeka","family":"Samarakoon","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Mongan Institute, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Mancini","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Mongan Institute, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Mongan Institute, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly G.","family":"Blumenthal","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Mongan Institute, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"issue":"7","key":"zoi210893r1","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1056\/NEJMra2035343","article-title":"Maintaining safety with SARS-CoV-2 vaccines.","volume":"384","author":"Castells","year":"2021","journal-title":"N Engl J Med"},{"issue":"50","key":"zoi210893r2","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.15585\/mmwr.mm6950e2","article-title":"The Advisory Committee on Immunization Practices\u2019 interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine\u2014United States, December 2020.","volume":"69","author":"Oliver","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5152","key":"zoi210893r3","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.15585\/mmwr.mm695152e1","article-title":"The Advisory Committee on Immunization Practices\u2019 interim recommendation for use of Moderna COVID-19 vaccine\u2014United States, December 2020.","volume":"69","author":"Oliver","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"15","key":"zoi210893r4","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1001\/jama.2021.3976","article-title":"Acute allergic reactions to mRNA COVID-19 vaccines.","volume":"325","author":"Blumenthal","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"zoi210893r5","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1001\/jama.2021.1967","article-title":"Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US\u2014December 14, 2020-January 18, 2021.","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"issue":"8","key":"zoi210893r6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.15585\/mmwr.mm7008e3","article-title":"First month of COVID-19 vaccine safety monitoring\u2014United States, December 14, 2020-January 13, 2021.","volume":"70","author":"Gee","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"zoi210893r7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.15585\/mmwr.mm7002e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine\u2014United States, December 14-23, 2020.","volume":"70","author":"CDC COVID-19 Response Team","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"zoi210893r8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.15585\/mmwr.mm7004e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine\u2014United States, December 21, 2020-January 10, 2021.","volume":"70","author":"CDC COVID-19 Response Team","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi210893r9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2021.06.006","article-title":"The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach.","author":"Greenhawt","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"n120","key":"zoi210893r10","doi-asserted-by":"crossref","first-page":"n120","DOI":"10.1136\/bmj.n120","article-title":"Vaccinating against covid-19 in people who report allergies.","volume":"372","author":"Glover","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"zoi210893r13","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.jaip.2020.12.047","article-title":"mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach.","volume":"9","author":"Banerji","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"zoi210893r15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.anai.2021.01.017","article-title":"Insights from American College of Allergy, Asthma, and Immunology COVID-19 vaccine task force: allergic reactions to mRNA SARS-CoV-2 vaccines.","volume":"126","author":"Murphy","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"zoi210893r16","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-147-8-200710160-00010-w1","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.","volume":"147","author":"Vandenbroucke","year":"2007","journal-title":"Ann Intern Med"},{"issue":"10","key":"zoi210893r17","doi-asserted-by":"crossref","DOI":"10.2196\/19533","article-title":"A web-based, mobile-responsive application to screen health care workers for COVID-19 symptoms: rapid design, deployment, and usage.","volume":"4","author":"Zhang","year":"2020","journal-title":"JMIR Form Res"},{"key":"zoi210893r19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02770903.2020.1857396","article-title":"COVID-19 severity in asthma patients: a multi-center matched cohort study.","author":"Robinson","year":"2021","journal-title":"J Asthma"},{"issue":"32","key":"zoi210893r20","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004554","article-title":"Defining and validating comorbidities and procedures in ICD-10 health data in ST-elevation myocardial infarction patients.","volume":"95","author":"Youngson","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"zoi210893r21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2377-13-16","article-title":"Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance.","volume":"13","author":"Marrie","year":"2013","journal-title":"BMC Neurol"},{"issue":"7424","key":"zoi210893r22","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1136\/bmj.327.7424.1142","article-title":"Increasing hospital admissions for systemic allergic disorders in England: analysis of national admissions data.","volume":"327","author":"Gupta","year":"2003","journal-title":"BMJ"},{"issue":"2","key":"zoi210893r23","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jaad.2020.09.084","article-title":"Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: a propensity score-matched cohort study.","volume":"84","author":"Schneeweiss","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"zoi210893r24","first-page":"188","article-title":"Charlson comorbidity index: ICD-9 update and ICD-10 translation.","volume":"12","author":"Glasheen","year":"2019","journal-title":"Am Health Drug Benefits"},{"issue":"11","key":"zoi210893r25","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index.","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"zoi210893r26","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jaci.2014.05.018","article-title":"Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals.","volume":"134","author":"Clark","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"zoi210893r27","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.jaip.2021.03.053","article-title":"COVID-19 vaccination in patients with reported allergic reactions: updated evidence and suggested approach.","volume":"9","author":"Banerji","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"zoi210893r28","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jaci.2015.07.048","article-title":"Risk of anaphylaxis after vaccination in children and adults.","volume":"137","author":"McNeil","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"zoi210893r29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.22255","article-title":"Prevalence of allergic reactions after Pfizer-BioNTech COVID-19 vaccination among adults with high allergy risk.","volume":"4","author":"Shavit","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"12","key":"zoi210893r30","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1111\/bcp.v85.12","article-title":"Immune-mediated adverse reactions to vaccines.","volume":"85","author":"Stone","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"zoi210893r31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.anai.2017.10.020","article-title":"Administration of influenza vaccines to egg allergic recipients: a practice parameter update 2017.","volume":"120","author":"Greenhawt","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"13","key":"zoi210893r32","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMc2102131","article-title":"Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2.","volume":"384","author":"Blumenthal","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi210893r33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases.","volume":"85","author":"McMahon","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"zoi210893r35","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2105\/AJPH.2016.303338","article-title":"Origin, methods, and evolution of the three nurses\u2019 health studies.","volume":"106","author":"Bao","year":"2016","journal-title":"Am J Public Health"},{"key":"zoi210893r36","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2021.3779","article-title":"Safety evaluation of the second dose of messenger RNA COVID-19 vaccines in patients with immediate reactions to the first dose.","author":"Krantz","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"3","key":"zoi210893r37","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jaci.2014.05.050","article-title":"Peanut allergy prevalence among school-age children in a US cohort not selected for any disease.","volume":"134","author":"Bunyavanich","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"zoi210893r11","unstructured":"Medicines and Healthcare Products Regulatory Agency. Confirmation of guidance to vaccination centres on managing allergic reactions following COVID-19 vaccination with the Pfizer\/BioNTech vaccine. December 9, 2020. Accessed April 9, 2021. https:\/\/www.gov.uk\/government\/news\/confirmation-of-guidance-to-vaccination-centres-on-managing-allergic-reactions-following-covid-19-vaccination-with-the-pfizer-biontech-vaccine"},{"key":"zoi210893r12","unstructured":"BSACI. Update on MHRA decision re: Pfizer COVID-19 Vaccination 30.12.20. Accessed April 9, 2021. https:\/\/www.bsaci.org\/update-on-mhra-decision-re-pfizer-covid-19-vaccination\/"},{"key":"zoi210893r14","unstructured":"Centers for Disease Control and Prevention. Prevaccination checklist for COVID-19 vaccines. Accessed March 8, 2021. https:\/\/www.cdc.gov\/vaccines\/covid-19\/downloads\/pre-vaccination-screening-form.pdf?"},{"key":"zoi210893r18","unstructured":"Centers for Disease Control and Prevention. Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. March 5, 2021. Accessed April 1, 2021. https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/clinical-considerations.html#Coadministration?"},{"key":"zoi210893r34","unstructured":"Systemic Allergic Reactions to SARS-CoV-2 Vaccination. ClinicalTrials.gov identifier: NCT04761822. Updated September 1, 2021. Accessed August 19, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04761822?"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2785466\/li_2021_oi_210893_1634576316.14306.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T16:18:17Z","timestamp":1635265097000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2785466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.31034","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,26]]}}}